OXUR Oxurion NV

0.0011USD0.0010 EUR · EBR+25.00%Mkt Cap: 255019 USDP/E: 0.01

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related…

Key Statistics

Company
Market Cap255.02K USD
Enterprise Value12.92M USD
Revenue (TTM)1.26M USD
Gross Profit610.06K USD
Net Income (TTM)-4.10M USD
Revenue/Share0.02 USD
Last Price0.0011 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees26
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0974487192
Valuation
P/E (Trailing)0.01
P/E (Forward)-0.00
PEG—
EV/EBITDA-5.30
EV/Revenue10.26
P/S0.20
P/B-0.01
EPS (TTM)0.11 USD
EPS (Forward)-0.52 USD
52W Range
0.00073% of range0.0136
52W High0.0136 USD
52W Low0.0007 USD
Profitability
Gross Margin100.00%
Oper. Margin-196.51%
EBITDA Margin-193.46%
Profit Margin-671.71%
ROE28.92%
ROA-97.46%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.87M USD
CapEx (TTM)—
FCF Margin-127.89%
FCF Yield-631.72%
Net Debt12.62M USD
Net Debt/EBITDA-5.18
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.89
Current Ratio0.09
Quick Ratio0.09
Book Value/Sh-0.16 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10000
Split DateSep 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.232.00M
Float55.56M
Insiders25.53%
Institutions0.00%
Technical
SMA 500.0014 (-18.8%)
SMA 2000.0035 (-68.8%)
Beta0.12
S&P 52W Chg12.00%
Avg Vol (30d)3.31M
Avg Vol (10d)2.55M
Technical Indicators
RSI (14)53.0
MACD-0.0001
MACD Signal-0.0002
MACD Hist.+0.0001
BB Upper0.0011 USD
BB Middle0.0008 USD
BB Lower0.0006 USD
BB Width55.07%
ATR (14)0.0003 USD
Vol Ratio (20d)3.80x

About Oxurion (EBR: OXUR)

›

Oxurion (EBR: OXUR) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 26 employees.

The shares were at 0.0010 EUR on 19 November 2026, down 91.9% over 52 weeks. Its 52-week range is 0.0006 EUR to 0.0124 EUR: the price is 91.9% below the high and 66.7% above the low.

Its market capitalisation is 232.00K EUR.

Oxurion reports return on equity of 28.9% and an operating margin of -196.5%.

Its debt exceeds its cash by 11.48M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.